NUS Income Statement Research

NUS Stock

USD 12.70 0.34 2.75%

Most accounts from Nu Skin's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Nu Skin Enterprises current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Nu Skin Valuation and Nu Skin Correlation analysis.

At this time, Nu Skin's Interest Expense is comparatively stable compared to the past year. Gross Profit is likely to gain to about 1.4 B in 2024, whereas Total Revenue is likely to drop slightly above 1.8 B in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	2.0B	1.6B	1.4B	1.4B
Total Revenue	2.7B	2.2B	2.0B	1.8B

Gross Profit Total Revenue

Nu Skin income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling General Administrative	Research Development	Selling And Marketing Expenses	Net Income From Continuing Ops	Non Operating Income Net Other	Tax Provision	Interest Income	Minority Interest	Reconciled Depreciation	Extraordinary Items	Non Recurring
Depreciation And Amortization		0.36	0.58	0.44	0.68	-0.11	-0.1	0.08	0.9	0.54	-0.11	-0.04	-0.08	-0.14	0.56	0.9	0.31	-0.31	-0.18	-0.11	0.51	0.08	0.4	0.01	-0.46
Interest Expense	0.36		-0.05	-0.16	0.04	-0.61	-0.59	-0.42	0.34	-0.08	-0.58	0.01	-0.49	-0.65	0.06	0.39	-0.19	-0.5	-0.01	-0.81	0.48	-0.66	-0.32	0.65	-0.97
Total Revenue	0.58	-0.05		0.98	0.99	0.69	0.69	0.82	0.79	1.0	0.66	0.05	0.66	0.6	0.7	0.66	0.93	0.47	0.01	0.18	0.19	0.22	0.35	-0.19	-0.04
Gross Profit	0.44	-0.16	0.98		0.95	0.8	0.8	0.9	0.66	0.99	0.77	0.06	0.75	0.71	0.64	0.54	0.97	0.59	0.03	0.26	0.07	0.24	0.29	-0.25	0.09
Other Operating Expenses	0.68	0.04	0.99	0.95		0.59	0.59	0.73	0.86	0.98	0.57	0.02	0.57	0.5	0.71	0.74	0.88	0.37	-0.03	0.11	0.26	0.18	0.37	-0.12	-0.13
Operating Income	-0.11	-0.61	0.69	0.8	0.59		1.0	0.94	0.15	0.72	0.98	0.14	0.95	0.93	0.33	0.02	0.83	0.9	0.19	0.56	-0.38	0.49	0.22	-0.49	0.56
Ebit	-0.1	-0.59	0.69	0.8	0.59	1.0		0.95	0.15	0.72	0.98	0.14	0.95	0.92	0.35	0.03	0.83	0.9	0.18	0.54	-0.4	0.48	0.2	-0.48	0.54
Ebitda	0.08	-0.42	0.82	0.9	0.73	0.94	0.95		0.31	0.84	0.91	0.06	0.87	0.87	0.49	0.2	0.94	0.79	0.12	0.41	-0.26	0.28	0.1	-0.39	0.36
Cost Of Revenue	0.9	0.34	0.79	0.66	0.86	0.15	0.15	0.31		0.75	0.14	0.0	0.17	0.07	0.7	0.89	0.55	-0.03	-0.07	-0.11	0.51	0.1	0.46	0.08	-0.46
Total Operating Expenses	0.54	-0.08	1.0	0.99	0.98	0.72	0.72	0.84	0.75		0.69	0.02	0.68	0.62	0.66	0.63	0.94	0.49	-0.01	0.19	0.15	0.21	0.31	-0.18	0.0
Income Before Tax	-0.11	-0.58	0.66	0.77	0.57	0.98	0.98	0.91	0.14	0.69		0.34	0.98	0.93	0.33	0.07	0.79	0.93	0.3	0.61	-0.33	0.54	0.29	-0.55	0.53
Total Other Income Expense Net	-0.04	0.01	0.05	0.06	0.02	0.14	0.14	0.06	0.0	0.02	0.34		0.37	0.24	0.07	0.23	0.04	0.39	0.62	0.38	0.15	0.39	0.37	-0.41	-0.02
Net Income	-0.08	-0.49	0.66	0.75	0.57	0.95	0.95	0.87	0.17	0.68	0.98	0.37		0.82	0.32	0.08	0.78	0.95	0.32	0.49	-0.32	0.58	0.29	-0.58	0.44
Income Tax Expense	-0.14	-0.65	0.6	0.71	0.5	0.93	0.92	0.87	0.07	0.62	0.93	0.24	0.82		0.32	0.03	0.73	0.79	0.25	0.73	-0.33	0.43	0.26	-0.43	0.61
Selling General Administrative	0.56	0.06	0.7	0.64	0.71	0.33	0.35	0.49	0.7	0.66	0.33	0.07	0.32	0.32		0.63	0.68	0.25	-0.09	0.15	0.4	0.08	0.43	-0.13	-0.22
Research Development	0.9	0.39	0.66	0.54	0.74	0.02	0.03	0.2	0.89	0.63	0.07	0.23	0.08	0.03	0.63		0.43	-0.12	-0.08	-0.03	0.61	0.06	0.39	0.04	-0.47
Selling And Marketing Expenses	0.31	-0.19	0.93	0.97	0.88	0.83	0.83	0.94	0.55	0.94	0.79	0.04	0.78	0.73	0.68	0.43		0.67	0.05	0.23	0.01	0.18	0.2	-0.25	0.12
Net Income From Continuing Ops	-0.31	-0.5	0.47	0.59	0.37	0.9	0.9	0.79	-0.03	0.49	0.93	0.39	0.95	0.79	0.25	-0.12	0.67		0.38	0.46	-0.4	0.51	0.19	-0.51	0.46
Non Operating Income Net Other	-0.18	-0.01	0.01	0.03	-0.03	0.19	0.18	0.12	-0.07	-0.01	0.3	0.62	0.32	0.25	-0.09	-0.08	0.05	0.38		0.2	-0.1	0.14	0.1	-0.14	-0.05
Tax Provision	-0.11	-0.81	0.18	0.26	0.11	0.56	0.54	0.41	-0.11	0.19	0.61	0.38	0.49	0.73	0.15	-0.03	0.23	0.46	0.2		-0.3	0.69	0.51	-0.7	0.74
Interest Income	0.51	0.48	0.19	0.07	0.26	-0.38	-0.4	-0.26	0.51	0.15	-0.33	0.15	-0.32	-0.33	0.4	0.61	0.01	-0.4	-0.1	-0.3		-0.27	0.36	0.28	-0.47
Minority Interest	0.08	-0.66	0.22	0.24	0.18	0.49	0.48	0.28	0.1	0.21	0.54	0.39	0.58	0.43	0.08	0.06	0.18	0.51	0.14	0.69	-0.27		0.71	-0.8	0.58
Reconciled Depreciation	0.4	-0.32	0.35	0.29	0.37	0.22	0.2	0.1	0.46	0.31	0.29	0.37	0.29	0.26	0.43	0.39	0.2	0.19	0.1	0.51	0.36	0.71		-0.44	0.22
Extraordinary Items	0.01	0.65	-0.19	-0.25	-0.12	-0.49	-0.48	-0.39	0.08	-0.18	-0.55	-0.41	-0.58	-0.43	-0.13	0.04	-0.25	-0.51	-0.14	-0.7	0.28	-0.8	-0.44		-0.61
Non Recurring	-0.46	-0.97	-0.04	0.09	-0.13	0.56	0.54	0.36	-0.46	0.0	0.53	-0.02	0.44	0.61	-0.22	-0.47	0.12	0.46	-0.05	0.74	-0.47	0.58	0.22	-0.61

Click cells to compare fundamentals

Nu Skin Account Relationship Matchups

Nu Skin income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	19.2M	13.1M	11M	21.9M	25.2M	26.4M
Total Revenue	2.4B	2.6B	2.7B	2.2B	2.0B	1.8B
Gross Profit	1.8B	1.9B	2.0B	1.6B	1.4B	1.4B
Operating Income	190.8M	257.6M	234.0M	110.8M	68.1M	64.7M
Ebit	190.8M	257.6M	234.0M	110.8M	68.1M	64.7M
Ebitda	267.4M	331.6M	337.7M	207.8M	137.7M	247.0M
Cost Of Revenue	581.4M	658.0M	675.2M	630.9M	611.9M	377.1M
Income Before Tax	255.2M	256.2M	232.5M	89.0M	26.6M	25.2M
Net Income	173.6M	191.4M	147.3M	104.8M	8.6M	8.2M
Income Tax Expense	81.6M	64.9M	85.2M	(15.8M)	18.0M	17.1M
Research Development	23M	30.1M	23.3M	27.2M	22.6M	18.1M
Tax Provision	81.6M	64.9M	85.2M	(15.8M)	(16.9M)	(16.1M)
Interest Income	19.2M	13.1M	11M	13.5M	15.5M	15.1M

Nu Skin Investors Sentiment

The influence of Nu Skin's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in NUS. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Nu Skin's public news can be used to forecast risks associated with an investment in NUS. The trend in average sentiment can be used to explain how an investor holding NUS can time the market purely based on public headlines and social activities around Nu Skin Enterprises. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Nu Skin's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Nu Skin's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Nu Skin's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Nu Skin.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Nu Skin in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Nu Skin's short interest history, or implied volatility extrapolated from Nu Skin options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Nu Skin Enterprises is a strong investment it is important to analyze Nu Skin's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nu Skin's future performance. For an informed investment choice regarding NUS Stock, refer to the following important reports:

How To Invest In NUS

Details

Is NUS Stock a good investment?

Details

What is Nu Skin's Net Worth?

Details

Largest Personal Care Products Companies

View

Largest Household & Personal Products Companies

View

Check out Nu Skin Valuation and Nu Skin Correlation analysis.

You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for NUS Stock analysis

When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.

	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios

Is Nu Skin's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nu Skin. If investors know NUS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nu Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.88)

Dividend Share

1.56

Earnings Share

0.17

Revenue Per Share

39.612

Quarterly Revenue Growth

(0.07)

The market value of Nu Skin Enterprises is measured differently than its book value, which is the value of NUS that is recorded on the company's balance sheet. Investors also form their own opinion of Nu Skin's value that differs from its market value or its book value, called intrinsic value, which is Nu Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nu Skin's market value can be influenced by many factors that don't directly affect Nu Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Nu Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nu Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nu Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

NUS Income Statement Research

Nu Skin income statement Correlations

Nu Skin Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Nu Skin income statement Accounts

Nu Skin Investors Sentiment

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for NUS Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Total Revenue
Ebit	+ 1.0	Operating Income
Other Operating Expenses	+ 0.99	Total Revenue
Total Operating Expenses	+ 0.99	Gross Profit
Gross Profit	+ 0.98	Total Revenue
Total Operating Expenses	+ 0.98	Other Operating Expenses

Non Recurring	- 0.97	Interest Expense
Tax Provision	- 0.81	Interest Expense
Extraordinary Items	- 0.8	Minority Interest
Extraordinary Items	- 0.7	Tax Provision
Minority Interest	- 0.66	Interest Expense
Income Tax Expense	- 0.65	Interest Expense